Tempus AI Insider Sales: 839,180 Shares Disposed Under 10b5-1 Plan
Rhea-AI Filing Summary
Ryan Fukushima, Chief Operating Officer of Tempus AI, Inc. (TEM), reported multiple sales of Class A common stock on September 2, 2025. The Form 4 states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted March 4, 2025. The filing lists a series of dispositions executed at weighted-average prices ranging from about $72.40 to $78.30, with specific weighted-average prices reported for groups of trades (for example, $72.73, $74.00, $74.95, $76.03, $76.77, $78.06). The reported entries show shares sold on that date and indicate indirect beneficial ownership through the reporting person’s spouse and an irrevocable family trust. The Form is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transactions executed under a documented Rule 10b5-1 trading plan, adopted March 4, 2025, indicating pre-established compliance with insider-trading rules
- Detailed price ranges and weighted-average prices are disclosed for each group of sales, improving transparency
Negative
- Large aggregate dispositions reported on a single date (September 2, 2025) including an entry showing 839,180 shares sold, which materially reduces insider-held shares
- Sales attributed to indirect holders (spouse and irrevocable family trust) could complicate interpretation of remaining insider ownership
Insights
TL;DR: Insider sales under a 10b5-1 plan on one date; routine compliance but reduces insider ownership.
The Form 4 documents multiple dispositions by the COO executed on September 2, 2025, under a documented 10b5-1 plan adopted March 4, 2025. Prices disclosed are weighted averages across multiple trade bands from approximately $72.40 to $78.30. The filing distinguishes direct and indirect holdings, noting sales by or attributed to the reporting person’s spouse and an irrevocable family trust. From an investor perspective, these are structured plan sales rather than opportunistic single trades, which limits immediate inference about management’s view of the company but does reduce reported insider holdings on the record date.
TL;DR: Disclosure follows SEC Section 16 rules and cites a pre-established 10b5-1 plan; documentation appears compliant.
The report clearly states the 10b5-1 trading plan adoption date and provides weighted-average price ranges and explanatory footnotes for multiple transactions. The filing identifies the reporting person, role (Chief Operating Officer), and indirect ownership via spouse and a family trust, and it is signed by an attorney-in-fact. The presentation aligns with typical insider-sale disclosures and provides the necessary explanatory detail for each price band, supporting regulatory transparency.